Morrisville, United States
Arrivo BioVentures LLC is a promising startup in the fields of Biopharma, Biotechnology, and Health Care, founded in 2015. The company prides itself on its slogan, "The Strength of a Trusted Partnership," and aims to establish a new benchmark in drug development. With a meticulous approach to selecting drug candidates and a commitment to excellence throughout the clinical development process, Arrivo has garnered a reputation for delivering outstanding returns and product successes. This track record has positioned the company as a trusted partner for industry and investors.
In a significant milestone, Arrivo recently secured a noteworthy $45.25M Series B investment on 29 November 2023. The investment was made by Rex Health Ventures, Solas BioVentures, and Orlando Health Ventures. This infusion of capital is indicative of the confidence that established investors have in Arrivo's potential for growth and success in the competitive and dynamic biotech landscape.
